Skip to main content
EXEL logo

Exelixis, Inc.

EXELNASDAQHealthcareBiotechnology

$62.83Today:- (-)1Y +60.24%

As of Oct 15, 2026 close

Market cap
$16.32B
P/E (TTM)
18.96
Forward P/E
13.89
Dividend yield
-
52-week range
$33.76$61.66
Volume (live)
-
Avg. volume (3M)
2.27M

Exelixis, Inc. (EXEL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Exelixis, Inc. stock.

Analyst Consensus Rating

Investment consensus from 15 professional research analysts

Consensus Rating

Hold
Based on 15 unique analysts
(22 total ratings in last 90 days)
High Confidence4.0:1 Buy/Sell

Average Price Target

$52.45
−16.52% downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest EXEL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jason Gerberry
BofA Securities
SellMaintains
$41.00
Leonid Timashev
RBC Capital
HoldMaintains
$45.00 → $51.00
Gregory Renza
Truist
HoldMaintains
$52.00 → $54.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Gregory Renza
Truist
HoldMaintains
-
Stephen Willey
Stifel Nicolaus
HoldMaintains
-
Jason Gerberry
BofA Securities
SellMaintains
$41.00
Andy Hsieh
William Blair
BuyReiterates
-
David Lebowitz
BMO Capital
HoldMaintains
$54.00
Unknown Analyst
Guggenheim
HoldMaintains
-
Unknown Analyst
Guggenheim
HoldMaintains
-
Unknown Analyst
BMO Capital
HoldMaintains
$54.00
Andy Hsieh
William Blair
BuyMaintains
-
Andrew Berens
Leerink Partners
HoldDowngrades
$52.00
Paul Choi
Goldman Sachs
BuyMaintains
$64.00
Etzer Darout
Barclays
HoldMaintains
$49.00
Eva Fortea Verdejo
Wells Fargo
HoldInitiates Coverage
$49.00 → $50.00
Leonid Timashev
RBC Capital
HoldMaintains
$46.00
Sean Laaman
Morgan Stanley
HoldMaintains
$53.00
Yaron Werber
TD Cowen
BuyMaintains
$55.00
Paul Choi
Goldman Sachs
BuyMaintains
$64.00
Jason Gerberry
BofA Securities
SellReiterates
$41.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for EXEL?

The analyst consensus rating for EXEL is Hold, based on the latest ratings from 15 analysts over the last 90 days.

What is the average price target for EXEL?

The average 12-month price target for EXEL is $52.45, representing a downside of 16.5% from the Oct 15, 2026 close of $62.83.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.